rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
1995-11-2
|
pubmed:abstractText |
Preexposure of HL-60 cells to a DNA-damaging agent, cytosine arabinoside (Ara-C), dramatically induced the levels of H1 kinase activities associated with cyclin E (CycE-H1K) but not cyclin A. This induction was cell cycle-independent and accompanied by loss of cell viability, a late event in apoptosis. When an Ara-C-resistant variant of HL-60 cells were treated with Ara-C at a low concentration, neither CycE-H1K nor apoptosis were observed. Both events were induced in the resistant cells but only after treatment with Ara-C at a much higher concentration for a longer period. The DNA-damage-induced CycE-H1K is proposed to be involved in a late apoptosis checkpoint.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0006-291X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
25
|
pubmed:volume |
214
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
771-80
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:7575543-Antimetabolites, Antineoplastic,
pubmed-meshheading:7575543-Apoptosis,
pubmed-meshheading:7575543-Cell Cycle,
pubmed-meshheading:7575543-Cell Survival,
pubmed-meshheading:7575543-Cyclin E,
pubmed-meshheading:7575543-Cyclin-Dependent Kinases,
pubmed-meshheading:7575543-Cyclins,
pubmed-meshheading:7575543-Cytarabine,
pubmed-meshheading:7575543-DNA Damage,
pubmed-meshheading:7575543-Drug Resistance, Neoplasm,
pubmed-meshheading:7575543-Enzyme Activation,
pubmed-meshheading:7575543-Flow Cytometry,
pubmed-meshheading:7575543-HL-60 Cells,
pubmed-meshheading:7575543-Humans,
pubmed-meshheading:7575543-Kinetics,
pubmed-meshheading:7575543-Protamine Kinase,
pubmed-meshheading:7575543-Time Factors
|
pubmed:year |
1995
|
pubmed:articleTitle |
Activation of cyclin E-dependent kinase by DNA-damage signals during apoptosis.
|
pubmed:affiliation |
Department of Pharmacology, University of Pittsburgh School of Medicine, PA, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|